60 likes | 75 Views
Breast Cancer Diagnostics Market is segmented by region, players, type and application u2013 proposed by The Business Research Company. http://bit.ly/3oOPICK
E N D
Global Global Breast Cancer Diagnostics Market ( Breast Cancer Diagnostics Market (Covid Growth Growth, , Opportunities, Strategies And Forecast To 2023 Opportunities, Strategies And Forecast To 2023 Covid- -19) 19) Analysis Analysis, , © The Business Research Company. All rights reserved. www.tbrc.info Email: info@tbrc.info
Market Characteristics Characteristics: : Breast Cancer Diagnostics Breast Cancer Diagnostics Market • The global breast cancer diagnostics market is expected to decline from $4.88 billion in 2019 to $4.62 billion in 2020 at a compound annual growth rate (CAGR) of -5.38%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, especially postponement of non- emergency procedures. The market is then expected to recover and reach $6.32 billion in 2023 at a CAGR of 10.99%. • The report covers the Breast Cancer Diagnostics market’s segments- 1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Others. 2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies. 3) By Cancer Type: BRCA Breast Cancer, ER & PR Breast Cancer, HER 2 Breast Cancer, EGFR Mutation Test Breast Cancer, Others. 4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-Ionizing Imaging Technologies. 5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers. Click Here To View Complete Report 2 © The Business Research Company. All rights reserved.
Major Key Players Major Key Players The major players covered in the breast cancer diagnostics market report are Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc, C. R. Bard Inc, Gamma Medica Inc, Aurora Imaging Technology Inc, Dilion Technologies Inc, Genomic Health, F. Hoffmann-La Roche Ltd, Micrima Limited, Provista Diagnostics Inc, Leica Biosystems Nussloch GmbH TBRC’s Annual Festive Sale Is Finally Here! Get Up To 50% Off On All Reports 3 © The Business Research Company. All rights reserved.
Reasons to Purchase Reasons to Purchase • Gain a truly global perspective with the most comprehensive market research report available on this market covering 60+ geographies. • Understand how the market is being affected by the COVID-19 and how it is likely to emerge and grow as the impact of the coronavirus abates. • Create regional and country strategies on the basis of local data and analysis. • Identify growth segments for investment. • Outperform competitors using market forecast data and the market drivers and trends shaping the global market. • Understand customers based on the latest market research findings. • Benchmark performance against key competitors of the market. Click Here To Get A Sample Report 4 The Business Research Company. All rights reserved.
Get In Touch Whatever your need be, at The Business Research Company we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. 5 © The Business Research Company. All rights reserved.
Europe Asia Americas The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE. +44 207 1930 708 Email: info@tbrc.info www.tbrc.info The Business Research Company, Horizon Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara Hills Hyderabad (India) 500033 ++91 8897263534 Email: info@tbrc.info www.tbrc.info The Business Research Company 625 South Avenue, Apt B204, Secane, Philadelphia, PA 19018, USA +1 3156230293 Email: info@tbrc.info www.tbrc.info 6 © The Business Research Company. All rights reserved.